BSEKerala Ayurveda LtdMediumNeutral
Announced Thu, 12 Feb · 16:11 IST

Acquisition- Ayurvedagram

Listed Co AcquisitionStrategic Transactions View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.1%1-day move
₹245.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-7.1-6.9-5.5-5.6-6.2-9.8-19.7-28.6+2.0-11.0
Up moveDown movePending
AI summary

On 12 February 2026, the board of Kerala Ayurveda Ltd approved four key items. First, standalone Q3 FY26 revenue from operations was Rs 22.07 cr with a loss of Rs 3.47 cr, while 9-month loss widened to Rs 6.81 cr; consolidated 9-month loss was Rs 8.93 cr on revenue of Rs 96.41 cr. Second, the company will issue up to 6,30,000 equity shares at Rs 327.99 each (~Rs 20.66 cr) to promoter-group entity Katra Holding Pvt Ltd to convert an outstanding unsecured loan. Third, it will acquire the remaining 26% stake in subsidiary Ayurvedagram Heritage Wellness Centre for ~Rs 10 cr, payable via issue of 304,887 shares at Rs 327.99 (share swap), making Ayurvedagram a wholly owned subsidiary. Ayurvedagram posted Rs 13.42 cr revenue and Rs 2.85 cr PAT in FY25. An EGM is scheduled for 14 March 2026 to seek shareholder approval, and 12,868 ESOP options were granted to employees at Rs 10 per option.

Likely market impact

The Ayurvedagram consolidation is a small, in-house housekeeping move (minority squeeze-in via share swap, no cash outflow) and is mildly EPS-dilutive due to the new share issuance. Loan-to-equity conversion from promoter group reduces debt but introduces promoter shareholding of about 4.96%, while widening losses and lack of profitability turnaround remain the key concern for shareholders.